{
"id":"mk19_bb_hm_s5",
"subspecialtyId":"hm",
"title":"Myeloproliferative Neoplasms",
"jsonContent":{
"type":"section",
"id":"mk19_bb_hm_s5",
"title":{
"__html":"Myeloproliferative Neoplasms"
},
"titleNode":{
"type":"section-title",
"hlId":"85f4ae",
"children":[
"Myeloproliferative Neoplasms"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_hm_s5_0",
"children":[
{
"type":"p",
"hlId":"7ec685",
"children":[
"The ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"myeloproliferative neoplasm",
"children":[
"MPN"
]
},
"s"
]
},
" are caused by acquired genetic defects in myeloid stem cells and are characterized by deregulated production of leukocytes, eosinophils, erythrocytes, or platelets. Although each disorder is named according to the dominant cell line affected, clinical features may overlap, and all can cause an elevation in several cell lines."
]
},
{
"type":"p",
"hlId":"b246e6",
"children":[
"MPNs may present with unusual thromboses; massive splenomegaly; or systemic symptoms. Each has a chronic phase that may progress to ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"acute myeloid leukemia",
"children":[
"AML"
]
},
"."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_bb_hm_s5_1",
"title":{
"__html":"Chronic Myeloid Leukemia"
},
"titleNode":{
"type":"section-title",
"hlId":"455d0c",
"children":[
"Chronic Myeloid Leukemia"
]
},
"children":[
{
"type":"p",
"hlId":"18931a",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Diagnosis:"
]
},
" Myeloid proliferation is associated with translocation of chromosomes 9 and 22 [t(9;22), the Philadelphia chromosome], which results in an abnormal tyrosine kinase (",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BCR-ABL"
]
},
") gene. Patients usually present in the chronic phase. ",
{
"type":"abbreviation",
"title":"chronic myeloid leukemia",
"children":[
"CML"
]
},
" has three phases: chronic (<10% myeloblasts), accelerated (10%-19% myeloblasts), and blast (≥20% myeloblasts)."
]
},
{
"type":"p",
"hlId":"d636ca",
"children":[
"Characteristic findings are splenomegaly, an elevated leukocyte count, and an increased number of granulocytic cells in all phases of maturation on the peripheral blood smear."
]
},
{
"type":"p",
"hlId":"c7845f",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Testing:"
]
},
" The diagnosis is confirmed through molecular testing for ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BCR-ABL"
]
},
" gene in the peripheral blood or bone marrow."
]
},
{
"type":"p",
"hlId":"864687",
"children":[
"Treatment is indicated for all patients with CML."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_hm_s5_inline_t1"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"399fe5",
"children":[
"All tyrosine kinase inhibitors can prolong the QT interval; periodic ",
{
"type":"abbreviation",
"title":"electrocardiogram",
"children":[
"ECG"
]
},
" monitoring is recommended."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_hm_s5_2",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"e29cac",
"class":"test",
"children":[
"An asymptomatic 54-year-old man has an enlarged spleen. The hemoglobin concentration is 13 g/dL, leukocyte count is 170,000/μL, and platelet count is 470,000/μL, with mostly segmented and band neutrophils and circulating metamyelocytes and myelocytes. Eosinophilia and basophilia are present."
]
},
{
"type":"p",
"hlId":"b6472d",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, choose CML. Confirm with ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BCR-ABL"
]
},
" gene detection in the peripheral blood."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_hm_s5_3",
"title":{
"__html":"Polycythemia Vera"
},
"titleNode":{
"type":"section-title",
"hlId":"b42441",
"children":[
"Polycythemia Vera"
]
},
"children":[
{
"type":"p",
"hlId":"8e8cdd",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Diagnosis:"
]
},
" ",
{
"type":"abbreviation",
"title":"polycythemia vera",
"children":[
"PV"
]
},
" causes erythropoietin-independent (low erythropoietin level) proliferation of erythrocytes. PV is suspected when the hemoglobin level is >16.5 g/dL in men or >16 g/dL in women after secondary causes are excluded. Most causes of secondary erythrocytosis are associated with an elevated erythropoietin level."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_bb_hm_s5_inline_t2"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"56f452",
"children":[
"Characteristic findings are thrombosis or bleeding, facial plethora, erythromelalgia, pruritus exacerbated by bathing in hot water, and splenomegaly. Serious complications may include ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"transient ischemic attack",
"children":[
"TIA"
]
},
","
]
},
" ",
{
"type":"abbreviation",
"title":"myocardial infarction",
"children":[
"MI"
]
},
" or stroke, ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"deep venous thrombosis",
"children":[
"DVT"
]
},
","
]
},
" and Budd-Chiari syndrome."
]
},
{
"type":"p",
"hlId":"5b2922",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Testing:"
]
},
" Patients have a low serum erythropoietin level in the setting of erythrocytosis."
]
},
{
"type":"p",
"hlId":"976c2b",
"children":[
"An activating mutation of ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" is present in 97% of patients with PV."
]
},
{
"type":"p",
"hlId":"27d214",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Treatment"
]
},
" is indicated for all patients with PV:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"ad3fc9",
"children":[
"therapeutic phlebotomy to hematocrit level <45%"
]
},
" ",
{
"type":"list-item",
"hlId":"eea2f1",
"children":[
"low-dose aspirin for all patients unless strong contraindications exist"
]
},
" ",
{
"type":"list-item",
"hlId":"81f675",
"children":[
"hydroxyurea or interferon-α for patients at highest risk for thrombosis (age >60 years; history of MI, ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"cerebrovascular accident",
"children":[
"CVA"
]
},
","
]
},
" ",
{
"type":"abbreviation",
"title":"venous thromboembolism",
"children":[
"VTE"
]
},
")"
]
},
" "
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"a213e9",
"children":[
"Hepatic vein thrombosis (the Budd-Chiari syndrome) or portal vein thrombosis should prompt consideration of PV even if erythrocytosis is absent."
]
},
" ",
{
"type":"list-item",
"hlId":"f94782",
"children":[
"Do not prescribe high-dose aspirin, which may cause increased bleeding."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_hm_s5_4",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"eec5a2",
"class":"test",
"children":[
"A 67-year-old man has intolerable pruritus. He does not smoke and takes no medications. The hematocrit value is 60%, and he has splenomegaly."
]
},
{
"type":"p",
"hlId":"c1d4d6",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, choose PV. For management, order ",
{
"type":"abbreviation",
"title":"polymerase chain reaction",
"children":[
"PCR"
]
},
" for ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" mutation and measure the erythropoietin level. For treatment, perform phlebotomy to hematocrit <45% and administer hydroxyurea and low-dose aspirin."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_hm_s5_5",
"title":{
"__html":"Essential Thrombocythemia"
},
"titleNode":{
"type":"section-title",
"hlId":"880b4d",
"children":[
"Essential Thrombocythemia"
]
},
"children":[
{
"type":"p",
"hlId":"51195a",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Diagnosis:"
]
},
" Essential thrombocythemia is characterized by thrombotic and hemorrhagic complications. It is marked by a predominant increase in megakaryocytes and platelet counts greater than 450,000/μL in the absence of more common secondary thrombocythemia, including iron deficiency, bleeding, cancer, infection, and chronic inflammatory disease. Many patients are asymptomatic. When they occur, symptoms include:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"160a73",
"children":[
"erythromelalgia (red and painful hands or feet with warmth and swelling)"
]
},
" ",
{
"type":"list-item",
"hlId":"b0cae3",
"children":[
"bleeding (when platelet count >1 million/μL)"
]
},
" ",
{
"type":"list-item",
"hlId":"380f43",
"children":[
"headache"
]
},
" ",
{
"type":"list-item",
"hlId":"cff26d",
"children":[
"vision symptoms"
]
},
" ",
{
"type":"list-item",
"hlId":"91fb34",
"children":[
"arterial or venous thromboses"
]
},
" "
]
},
{
"type":"p",
"hlId":"ddc221",
"children":[
"Splenomegaly (up to 50%) may be present. The ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" mutation is found in about half of patients (other mutations occur in the calreticulin [",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"CAL-R"
]
},
"] or ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"MPL"
]
},
" receptors) and helps distinguish essential thrombocythemia from secondary thrombocythemia."
]
},
{
"type":"p",
"hlId":"cdb641",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Treatment"
]
},
" depends on risk factors and complications:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"21e768",
"children":[
"low-risk patients ",
{
"type":"alert",
"children":[
"(age <60 years; ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" negative; no previous MI, stroke, or VTE)"
]
},
" → low-dose aspirin, which reduces vasomotor symptoms (such as erythromelalgia)"
]
},
" ",
{
"type":"list-item",
"hlId":"2e20f3",
"children":[
"high-risk patients ",
{
"type":"alert",
"children":[
"(age >60 years, ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" positive ± previous MI, CVA, VTE)"
]
},
" → hydroxyurea plus aspirin"
]
},
" ",
{
"type":"list-item",
"hlId":"190b87",
"children":[
"pregnant high-risk patients → ",
{
"type":"alert",
"children":[
"interferon-α"
]
}
]
},
" ",
{
"type":"list-item",
"hlId":"88c673",
"children":[
"acute, serious thrombotic or hemorrhagic events and platelet count >1 million/μL → plateletpheresis"
]
},
" "
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"90d88a",
"children":[
"The most common causes of thrombocythemia are iron deficiency anemia and infection, and platelet counts will improve within a couple of weeks following treatment of the underlying condition."
]
},
" ",
{
"type":"list-item",
"hlId":"cf82ae",
"children":[
"A negative ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" test does not exclude the diagnosis of essential thrombocythemia."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_hm_s5_6",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"99c66f",
"class":"test",
"children":[
"A 67-year-old man is evaluated because of red, warm, painful feet and a platelet count of 975,000/μL. Medical history is positive for previous MI."
]
},
{
"type":"p",
"hlId":"08b09c",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, choose essential thrombocythemia. For management, prescribe hydroxyurea and low-dose aspirin."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_hm_s5_7",
"title":{
"__html":"Primary Myelofibrosis"
},
"titleNode":{
"type":"section-title",
"hlId":"c1cd73",
"children":[
"Primary Myelofibrosis"
]
},
"children":[
{
"type":"p",
"hlId":"b7869e",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Diagnosis:"
]
},
" Primary myelofibrosis results from clonal proliferation of abnormal hematopoietic stem cells that release fibrosis-promoting cytokines. The disorder is characterized by massive splenomegaly, normocytic anemia, circulating erythroblasts and immature myeloid precursors, giant platelets, and teardrop erythrocytes. Bone marrow biopsy confirms fibrosis because the aspirate is a “dry tap.” Splenomegaly and hepatomegaly result from extramedullary hematopoiesis, and patients can develop portal hypertension. ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"CAL-R"
]
},
", and ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"MPL"
]
},
" mutations are common. Death commonly results from bone marrow failure, transformation to acute leukemia, or portal hypertension complications."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_bb_hm_f02"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"80ae37",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Treatment"
]
},
" is usually supportive."
]
},
{
"type":"p",
"hlId":"558b8e",
"children":[
"Hydroxyurea and ruxolitinib or fedratinib (",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" inhibitors) may alleviate splenomegaly and constitutional symptoms."
]
},
{
"type":"p",
"hlId":"74bd13",
"children":[
"Allogeneic ",
{
"type":"abbreviation",
"title":"hematopoietic stem cell transplantation",
"children":[
"HSCT"
]
},
" is indicated for patients <60 years of age with high-risk disease."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"d7af00",
"children":[
"Splenectomy should be avoided because it is associated with hemorrhagic and thrombotic complications, increased risk of progression to leukemia, and no effect on survival."
]
},
" "
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_hm_s5_inline_t1":{
"id":"mk19_bb_hm_s5_inline_t1",
"number":1,
"bookId":"hm",
"title":{
"__html":"Study Table: Treatment for CML"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"9e0b26",
"children":[
"Study Table: Treatment for CML"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c4ac0",
"class":"col hd l",
"children":[
"Treatment"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"12c742",
"class":"col hd l",
"children":[
"Goal"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1531ec",
"class":"cell txt l",
"children":[
"Tyrosine kinase inhibitors: imatinib, dasatinib, nilotinib, bosutinib, ponatinib"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fdeb84",
"class":"cell txt l",
"children":[
"Disease control with lifelong treatment"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"99d695",
"class":"cell txt l",
"children":[
"Allogeneic ",
{
"type":"abbreviation",
"title":"hematopoietic stem cell transplantation",
"children":[
"HSCT"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"051884",
"class":"cell txt l",
"children":[
"Potential cure for some patients with accelerated disease or blast crisis"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_bb_hm_s5_inline_t2":{
"id":"mk19_bb_hm_s5_inline_t2",
"number":2,
"bookId":"hm",
"title":{
"__html":"Study Table: Causes of Erythrocytosis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"bf8b9e",
"children":[
"Study Table: Causes of Erythrocytosis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"84a4b6",
"class":"col hd l",
"children":[
"Disorders"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bcba3f",
"class":"col hd l",
"children":[
"Symptoms and Suggestive Medical History"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"94eef1",
"class":"col hd l",
"children":[
"Physical Examination"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"590fa5",
"class":"col hd l",
"children":[
"Laboratory Studies"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2b270c",
"class":"cell txt l",
"children":[
"PV (primary)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1c5c79",
"class":"cell txt l",
"children":[
"Pruritus after a warm shower"
]
},
" ",
{
"type":"p",
"hlId":"9cf343",
"class":"cell txt l",
"children":[
"Erythromelalgia",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"e2948f",
"class":"cell txt l",
"children":[
"TIA"
]
},
" ",
{
"type":"p",
"hlId":"ca7271",
"class":"cell txt l",
"children":[
"Thrombosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bc21ef",
"class":"cell txt l",
"children":[
"Splenomegaly"
]
},
" ",
{
"type":"p",
"hlId":"88a4b8",
"class":"cell txt l",
"children":[
"Plethora"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"86082a",
"class":"cell txt l",
"children":[
"Low erythropoietin"
]
},
" ",
{
"type":"p",
"hlId":"44527d",
"class":"cell txt l",
"children":[
"Leukocytosis"
]
},
" ",
{
"type":"p",
"hlId":"b5f566",
"class":"cell txt l",
"children":[
"Basophilia"
]
},
" ",
{
"type":"p",
"hlId":"8559a0",
"class":"cell txt l",
"children":[
"Thrombocytosis"
]
},
" ",
{
"type":"p",
"hlId":"db69e4",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" positive"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0c7075",
"class":"cell txt l",
"children":[
"Mediated by hypoxemia"
]
},
" ",
{
"type":"p",
"hlId":"2a62ff",
"class":"cell txt li",
"children":[
" ",
{
"type":"abbreviation",
"title":"chronic obstructive pulmonary disease",
"children":[
"COPD"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"7fede4",
"class":"cell txt li",
"children":[
"Sleep apnea"
]
},
" ",
{
"type":"p",
"hlId":"9513b0",
"class":"cell txt li",
"children":[
"Congenital heart disease"
]
},
" ",
{
"type":"p",
"hlId":"bff278",
"class":"cell txt li",
"children":[
"Intrapulmonary shunting"
]
},
" ",
{
"type":"p",
"hlId":"8b05db",
"class":"cell txt li",
"children":[
"High elevation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ca7271",
"class":"cell txt l",
"children":[
"Thrombosis"
]
},
" ",
{
"type":"p",
"hlId":"e2948f",
"class":"cell txt l",
"children":[
"TIA"
]
},
" ",
{
"type":"p",
"hlId":"31f998",
"class":"cell txt l",
"children":[
"Erythromelalgia uncommon"
]
},
" ",
{
"type":"p",
"hlId":"8cf4c8",
"class":"cell txt l",
"children":[
"Pruritus uncommon"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"88a4b8",
"class":"cell txt l",
"children":[
"Plethora"
]
},
" ",
{
"type":"p",
"hlId":"096b13",
"class":"cell txt l",
"children":[
"No splenomegaly"
]
},
" ",
{
"type":"p",
"hlId":"c2082d",
"class":"cell txt l",
"children":[
"Findings consistent with underlying heart or lung disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0885e6",
"class":"cell txt l",
"children":[
"Normal leukocyte count"
]
},
" ",
{
"type":"p",
"hlId":"cbdaa1",
"class":"cell txt l",
"children":[
"Normal platelet count"
]
},
" ",
{
"type":"p",
"hlId":"af7c14",
"class":"cell txt l",
"children":[
"No basophilia"
]
},
" ",
{
"type":"p",
"hlId":"c62156",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" negative"
]
},
" ",
{
"type":"p",
"hlId":"abe704",
"class":"cell txt l",
"children":[
"Decreased oxygen saturation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ab4cc1",
"class":"cell txt l",
"children":[
"Mediated by ectopic or excessive erythropoietin"
]
},
" ",
{
"type":"p",
"hlId":"37475b",
"class":"cell txt li",
"children":[
"Renal cell carcinoma"
]
},
" ",
{
"type":"p",
"hlId":"6ab97c",
"class":"cell txt li",
"children":[
"Renal artery stenosis/other kidney pathology"
]
},
" ",
{
"type":"p",
"hlId":"4f8771",
"class":"cell txt li",
"children":[
"Hepatocellular carcinoma"
]
},
" ",
{
"type":"p",
"hlId":"a091bc",
"class":"cell txt li",
"children":[
"Uterine fibroids"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cfcb16",
"class":"cell txt l",
"children":[
"Thrombosis possible"
]
},
" ",
{
"type":"p",
"hlId":"7189d6",
"class":"cell txt l",
"children":[
"TIA uncommon"
]
},
" ",
{
"type":"p",
"hlId":"31f998",
"class":"cell txt l",
"children":[
"Erythromelalgia uncommon"
]
},
" ",
{
"type":"p",
"hlId":"8cf4c8",
"class":"cell txt l",
"children":[
"Pruritus uncommon"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"88a4b8",
"class":"cell txt l",
"children":[
"Plethora"
]
},
" ",
{
"type":"p",
"hlId":"096b13",
"class":"cell txt l",
"children":[
"No splenomegaly"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9b2f20",
"class":"cell txt l",
"children":[
"High erythropoietin"
]
},
" ",
{
"type":"p",
"hlId":"2e8993",
"class":"cell txt l",
"children":[
"Microscopic hematuria (renal cell carcinoma)"
]
},
" ",
{
"type":"p",
"hlId":"05d657",
"class":"cell txt l",
"children":[
"Abnormal finding on kidney ultrasonography"
]
},
" ",
{
"type":"p",
"hlId":"af7c14",
"class":"cell txt l",
"children":[
"No basophilia"
]
},
" ",
{
"type":"p",
"hlId":"c62156",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" negative"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a69f04",
"class":"cell txt l",
"children":[
"Unusual causes"
]
},
" ",
{
"type":"p",
"hlId":"6d86cc",
"class":"cell txt li",
"children":[
"High oxygen affinity hemoglobin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ca7271",
"class":"cell txt l",
"children":[
"Thrombosis"
]
},
" ",
{
"type":"p",
"hlId":"e2948f",
"class":"cell txt l",
"children":[
"TIA"
]
},
" ",
{
"type":"p",
"hlId":"31f998",
"class":"cell txt l",
"children":[
"Erythromelalgia uncommon"
]
},
" ",
{
"type":"p",
"hlId":"8cf4c8",
"class":"cell txt l",
"children":[
"Pruritus uncommon"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"88a4b8",
"class":"cell txt l",
"children":[
"Plethora"
]
},
" ",
{
"type":"p",
"hlId":"096b13",
"class":"cell txt l",
"children":[
"No splenomegaly"
]
},
" ",
{
"type":"p",
"hlId":"d1b374",
"class":"cell txt l",
"children":[
"Age <30 years"
]
},
" ",
{
"type":"p",
"hlId":"a38ec9",
"class":"cell txt l",
"children":[
"Family history of erythrocytosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9b2f20",
"class":"cell txt l",
"children":[
"High erythropoietin"
]
},
" ",
{
"type":"p",
"hlId":"af7c14",
"class":"cell txt l",
"children":[
"No basophilia"
]
},
" ",
{
"type":"p",
"hlId":"611b42",
"class":"cell txt l",
"children":[
"No leukocytosis"
]
},
" ",
{
"type":"p",
"hlId":"c62156",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" negative"
]
},
" ",
{
"type":"p",
"hlId":"bfac18",
"class":"cell txt l",
"children":[
"Abnormal hemoglobin electrophoresis"
]
},
" ",
{
"type":"p",
"hlId":"6e4477",
"class":"cell txt l",
"children":[
"Low P50",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Intermittently red, hot, painful extremities."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"P50 is the point on the oxyhemoglobin dissociation curve where the hemoglobin molecule is half saturated with oxygen, indicating an increased hemoglobin affinity for oxygen and reduced oxygen delivery to tissues."
]
]
}
}
}